Skip to main content
SpringerLink
Log in

Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?

  • Published:
Journal of Gastrointestinal Surgery

Abstract

Recent studies suggest that neoadjuvant chemoradiation can downstage locally advanced pancreatic tumors. There is limited evaluable data to support this approach. We review our experience with preoperative chemoradiation for surgically staged, locally advanced pancreatic cancer to determine whether patients are downstaged with multimodal therapy allowing for curative resection. A prospectively collected database from Memorial Sloan-Kettering Cancer Center was reviewed. Patients admitted between January 1993 and March 1999 with locally advanced pancreatic adenocarcinoma were identified (N = 163). Chemoradiation was administered to 87 (53.3%) of 163, and regimens varied from standard 5-fluorouracil/gemcitabine-based therapies to experimental protocols. Only three patients (3/87; 3.4%) had a sufficient clinical response on restaging to warrant reexploration. Of these, two thirds were unresectable on subsequent laparoscopy because of extensive vascular involvement or metastatic disease. Only one patient underwent a potentially curative resection, with a survival of 18 months despite negative margins and no nodal involvement. The overall median survival for all patients with locally advanced disease treated with chemoradiation was 11 months (6.5 months without multimodal therapy; P = 0.004). Although hemora-diation is associated with improved overall survival in locally advanced disease, it rarely leads to surgical “downstaging” allowing for potentially curative pancreatic resections. Novel multimodality approaches are required.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Conlon KC, Klimstra DS, Brennan MF. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 1996;223:273–279.

    Article  PubMed  CAS  Google Scholar 

  2. Pisters PW, Abbruzzese JL, Janjan NA, Cleary KR, Charnsangavej C, Goswitz MS, Rich TA, Raijman I, Wolff RA, Lenzi R, Lee JE, Evans DB. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. J Clin Oncol 1998;16:3843–3850.

    PubMed  CAS  Google Scholar 

  3. Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, Hruban RH, Ord SE, Sauter PK, Coleman J, Zahurak ML, Grochow LB, Abrams RA. Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s: Pathology, complications, and outcomes. Ann Surg 1997;226:248–257.

    Article  PubMed  CAS  Google Scholar 

  4. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics, 2000. CA Cancer J Clin 2000;50:7–33.

    Article  PubMed  CAS  Google Scholar 

  5. Janes RH Jr, Niederhuber JE, Chmiel JS, Winchester DP, Ocwieja KC, Karnell JH, Clive RE, Menck HR. National patterns of care for pancreatic cancer. Results of a survey by the commission on cancer. Ann Surg 1996;223:261–272.

    Article  PubMed  Google Scholar 

  6. Wade TP, Radford DM, Virgo KS, Johnson FE. Complications and outcomes in the treatment of pancreatic adenocarcinoma in the United States veteran. J Am Coll Surg 1994;179:38–48.

    PubMed  CAS  Google Scholar 

  7. Wade TP, Halaby IA, Stapleton DR, Virgo KS, Johnson FE. Population-based analysis of treatment of pancreatic cancer and Whipple resection: Department of Defense Hospitals, 1989–1994. Surgery 1996;120:680–685.

    Article  PubMed  CAS  Google Scholar 

  8. Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg 1996;223:506–511.

    Article  PubMed  CAS  Google Scholar 

  9. Evans DB, Rich TA, Byrd DR, Ames FC. Adenocarcinoma of the pancreas: Current management of resectable and locally advanced disease. South MedJ 1991;84:566–570.

    CAS  Google Scholar 

  10. Miller AR, Robinson EK, Lee JE, Pisters PW, Chiao PJ, Lenzi RL, Abbruzzese JL, Evans DB. Neoadjuvant chemoradiation for adenocarcinoma of the pancreas. Surg Oncol Clin North Am 1998;7:183–197.

    CAS  Google Scholar 

  11. Howard JM. Development and progress in resective surgery for pancreatic cancer. World J Surg 1999;23:901–906.

    Article  PubMed  CAS  Google Scholar 

  12. Whipple AO, Parsons WB, Mullins CR. Treatment of carcinoma of the ampulla of Vater. Ann Surg 1935;102:763.

    Article  PubMed  CAS  Google Scholar 

  13. Trede M, Schwall G, Saeger HD. Survival after pancre-atoduodenectomy. 118 consecutive resections without an operative mortality. Ann Surg 1990;211:447–458.

    Article  PubMed  CAS  Google Scholar 

  14. Yeo CJ, Cameron JL. Improving results of pancreaticoduodenectomy for pancreatic cancer. World J Surg 1999; 23:907–912.

    Article  PubMed  CAS  Google Scholar 

  15. Cameron JL, Crist DW, Sitzmann JV, Hruban RH, Boitnott JK, Seidler AJ, Coleman J. Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 1991;161:120–124.

    Article  PubMed  CAS  Google Scholar 

  16. Fernandez-del Castillo C, Rattner DW, Warshaw AL. Standards for pancreatic resection in the 1990s. Arch Surg 1995;130:295–299.

    Google Scholar 

  17. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993;165:68–72.

    Article  PubMed  CAS  Google Scholar 

  18. Nitecki SS, Sarr MG, Colby TV, van Heerden JA. Longterm survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995;221:59–66.

    CAS  Google Scholar 

  19. Pisters PW, Abbruzzese JL, Janjan NA, Cleary KR, Charnsangavej C, Goswitz MS, Rich TA, Raijman I, Wolff RA, Lenzi R, Lee JE, Evans DB. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. J Clin Oncol 1998;16:3843–3850.

    PubMed  CAS  Google Scholar 

  20. Staley CA, Lee JE, Cleary KR, Abbruzzese JL, Fenoglio CJ, Rich TA, Evans DB. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 1996;171:118–124.

    Article  PubMed  CAS  Google Scholar 

  21. Hoffman JP, O’Dwyer P, Agarwal P, Salazar H, Ahmad N. Preoperative chemoradiotherapy for localized pancreatic carcinoma. A perspective. Cancer 1996;78(Suppl 3):592–527.

    PubMed  CAS  Google Scholar 

  22. Hoffman JP, Lipsitz S, Pisansky T, WeeseJL, Solin L, Benson AB III. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group study. J Clin Oncol 1998;16:317–323.

    PubMed  CAS  Google Scholar 

  23. Moertel CG, Frytak S, Hahn RG, O’Connell MJ, Reitemeier RJ, Rubin J, Schutt AJ, Weiland LH, Childs DS, Holbrook MA, Lavin PT, Livstone E, Spiro H, Knowlton A, Kalser M, Barkin J, Lessner H, Mann-Kaplan R, Ramming K, Douglas HO Jr, Thomas P, Nave H, Bateman J, Lokich J, Brooks J, Chaffey J, Corson JM, Zamcheck N, Novak JW. Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group. Cancer 1981;48:1705–1710.

    Article  PubMed  CAS  Google Scholar 

  24. Neoptolemos JP, Kerr DJ, Beger H, Link K, Pederzoli P, Bassi C, Dervenis C, Fernandez-Cruz L, Lacaine F, Friess H, Buchler M. ESPAC-1 trial progress report: The European randomized adjuvant study comparing radiochemotherapy, 6 months chemotherapy and combination therapy versus observation in pancreatic cancer. Digestion 1997;58:570–577.

    Article  PubMed  CAS  Google Scholar 

  25. Neoptolemos JP, Baker P, Beger H, Link K, Pederzoli P, Bassi C, Dervenis C, Friess H, Buchler M. Progress report. A randomized multicenter European study comparing adjuvant radiotherapy, 6-mo chemotherapy, and combination therapy vs no-adjuvant treatment in resectable pancreatic cancer (ESPAC-1). Int J Pancreatol 1997;21:97–104.

    PubMed  CAS  Google Scholar 

  26. Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A, Wils J. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group. Ann Surg 1999;230:776–782.

    Article  PubMed  CAS  Google Scholar 

  27. Bousquet J, Slim K, Pezet D, Alexandre M, Verrelle P, Cure H, Chipponi J. [Does neoadjuvant radiochemotherapy augment the resectability of pancreatic cancers?]. Chirurgie 1998; 123:456–460.

    Article  PubMed  CAS  Google Scholar 

  28. Bruckner HW, Kalnicki S, Dalton J, Snady H, Schwartz GK, Chesser MR, Lehrer D, Mandeli J, Harpaz N, Janus C. Survival after combined modality therapy for pancreatic cancer. J Clin Gastroenterol 1993; 16:199–203.

    Article  PubMed  CAS  Google Scholar 

  29. Jessup JM, Steele G Jr, Mayer RJ, Posner M, Busse P, Cady B, Stone M, Jenkins R, Osteen R. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 1993; 128:559–564.

    PubMed  CAS  Google Scholar 

  30. Kamthan AG, Morris JC, Dalton J, Mandeli JP, Chesser MR, Leben D, Cooperman A, Bruckner HW. Combined modality therapy for stage II and stage III pancreatic carcinoma. J Clin Oncol 1997;15:2920–2927.

    PubMed  CAS  Google Scholar 

  31. Pilepich MV, Miller HH. Preoperative irradiation in carcinoma of the pancreas. Cancer 1980;46:1945–1949.

    Article  PubMed  CAS  Google Scholar 

  32. Snady H, Bruckner H, Cooperman A, Paradiso J, Kiefer L. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial. Cancer 2000;89:314–327.

    Article  PubMed  CAS  Google Scholar 

  33. Spitz FR, Abbruzzese JL, Lee JE, Pisters PW, Lowy AM, Fenoglio CJ, Cleary KR, Janjan NA, Goswitz MS, Rich TA, Evans DB. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997;15:928–937.

    PubMed  CAS  Google Scholar 

  34. Staley CA, Lee JE, Cleary KR, Abbruzzese JL, Fenoglio CJ, Rich TA, Evans DB. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head. Am J Surg 1996; 171:118–124.

    Article  PubMed  CAS  Google Scholar 

  35. Todd KE, Gloor B, Lane JS, Isacoff WH, Reber HA. Resection of locally advanced pancreatic cancer after down-staging with continuous-infusion 5-fluorouracil, mitomycin-C, leucovorin, and dipyridamole. J GASTROINTEST Surg 1998; 2:159–166.

    Article  PubMed  CAS  Google Scholar 

  36. Wanebo HJ, Glicksman AS, Vezeridis MP, Clark J, Tibbetts L, Koness RJ, Levy A. Preoperative chemotherapy, radiotherapy, and surgical resection of locally advanced pancreatic cancer. Arch Surg 2000;135:81–87.

    Article  PubMed  CAS  Google Scholar 

  37. White R, Lee C, Anscher M, Gottfried M, Wolff R, Keogan M, Pappas T, Hurwitz H, Tyler D. Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas. Ann Surg Oncol 1999;6:38–45.

    Article  PubMed  Google Scholar 

  38. Yeung RS, Weese JL, Hoffman JP, Solin LJ, Paul AR, Engstrom PF, Litwin S, Kowalyshyn MJ, Eisenberg BL. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A phase II study. Cancer 1993;722:124–133.

    Google Scholar 

  39. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J R Stat Soc 1958;8:423–446.

    Google Scholar 

  40. Conlon KC, Dougherty E, Klimstra DS, Coit DG, Turnbull AD, Brennan MF. The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg 1996;223:134–140.

    Article  PubMed  CAS  Google Scholar 

  41. Bajetta E, Di Bartolomeo M, Stani SC, Artale S, Ricci SB, Bozzetti F, Mazzaferro V, Toffolatti L, Buzzoni R. Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: Results of a feasibility study. Int J Radiat Oncol Biol Phys 1999;45:285–289.

    Article  PubMed  CAS  Google Scholar 

  42. Morganti AG, Trodella L, Valentini V, Doglietto GB, Ziccarelli P, Macchia G, Alfieri S., Smaniotto D, Luzi S, Brizi MG, Fadda G, Fiorino M, Di Gesu C, Cellini N. [Preoperative radiochemotherapy in pancreatic cancer: Preliminary results]. Tumori 1999;85(Suppl 1):S27-S32.

    PubMed  CAS  Google Scholar 

  43. Poen JC, Ford JM, Niederhuber JE. Chemoradiotherapy in the management of localized tumors of the pancreas. Ann Surg Oncol 1999;6:117–122.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York

    Hong Jin Kim M.D., Karen Czischke B.S., Murray F. Brennan M.D. & Kevin C. Conlon M.D.

Authors
  1. Hong Jin Kim M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Karen Czischke B.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Murray F. Brennan M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kevin C. Conlon M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kim, H.J., Czischke, K., Brennan, M.F. et al. Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?. J Gastrointest Surg 6, 763–769 (2002). https://doi.org/10.1016/S1091-255X(02)00017-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1016/S1091-255X(02)00017-3

Key words

Search

Navigation